Thursday 31st March 2022 |
Text too small? |
Cannasouth Limited (NZX: CBD , Cannasouth), today released its Annual Report for the year ended 31 December 2021.
Changes versus 2021 Unaudited Preliminary Results
On 1 March 2022 Cannasouth released to the market its preliminary results for the year ended 31 December 2021 (Preliminary Results). The table in the attached '2021 Annual Report Announcement' document summarises the key results.
The Preliminary Results were prepared on the basis that the accounting treatment for the acquisition of Midwest Pharmaceutics NZ Ltd and Cannasouth Cultivation Ltd was subject to audit. The reclassification of pre-acquisition transactions has no cash flow impacts.
Included with this announcement are the following documents:
• 2021 Annual Report
• Revised Results Announcement Form
-ENDS-
No comments yet
NZAS Sign Long Term Contracts
Amended - IFT230 Maturity and Exchange for IFT350
Synlait forecast milk price update
Chorus submits 2023 fibre regulatory report
Infratil Infrastructure Bond Exchange Offer opens
May 31st Morning Report
NZAS and Mercury sign long-term agreement, creating opportunity for future investment in renewables
Meridian and NZAS sign long term contracts
ArborGen Holdings Results for Year Ended 31 March 2024
BAI - Full unaudited results to 31 March 2024